Corrigendum

Laboratory Investigation (2008) 88, 450; doi:10.1038/labinvest.2008.9

Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma

Michelle L Gervais, Pauline C Henry, Arthy Saravanan, T Nadine Burry, Brenda L Gallie, Michael A S Jewett, Richard P Hill, Andrew J Evans and Michael Ohh

Correction to: Laboratory Investigation (2007) 87, 1252–1264; doi:10.1038/labinvest.3700684; published online 1 October 2007

In this article, the third author, Liz Taylor-Edmonds, was omitted from the authors' list. The corrected author's list is as follows:

Michelle L Gervais, Pauline C Henry, Liz Taylor-Edmonds, Arthy Saravanan, T Nadine Burry, Brenda L Gallie, Michael AS Jewett, Richard P Hill, Andrew J Evans and Michael Ohh

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

REVIEWS

Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies

Nature Clinical Practice Oncology Review (01 Jul 2006)

NEWS AND VIEWS

Ankyrin for clues about the function 0fp16 INK4a

Nature Structural Biology News and Views (01 Feb 1998)

Extra navigation

.

naturejobs

ADVERTISEMENT